Concepedia

Gerard M. McGeehan

GM

Statistics

Publications

52

Citations

5.8K

H-Index

29

Active since

1983

Affiliations

Synta Pharmaceuticals (United States)(Current)

Research Triangle Park Foundation

Dana-Farber Cancer Institute

Memorial Sloan Kettering Cancer Center

Boston Children's Hospital

Gerard M. McGeehan is an author at Synta Pharmaceuticals (United States) specializing in molecular biology, life sciences, and pharmacology.

Publications per year

1983–2023

52

Publications

52

Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α

Marcia L. Moss, S.-L. Catherine Jin, Marcos E. Milla et al. · Nature · 1997 · 1.6K citations

, , +11

Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor

Gerard M. McGeehan, J. David Becherer, Robert C. Bast et al. · Nature · 1994 · 571 citations

, , +14

The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia

Ghayas C. Issa, Ibrahim Aldoss, John F. DiPersio et al. · Nature · 2023 · 468 citations · Full text

, , +13

A Menin-MLL Inhibitor Induces Specific Chromatin Changes and Eradicates Disease in Models of MLL-Rearranged Leukemia

Andrei V. Krivtsov, Kathryn Evans, Jayant Y. Gadrey et al. · Cancer Cell · 2019 · 449 citations · Full text

, , +14

Structure of the Catalytic Domain of Fibroblast Collagenase Complexed with an Inhibitor

Brett Lovejoy, Anne Cleasby, Anne M. Hassell et al. · Science · 1994 · 332 citations

, , +15

1–5 of 52